Advancing diagnostics and detection of neovascular age-related macular degeneration
February 29th 2016Early detection and treatment is essential to preserve vision in patients with age-related macular degeneration. A new device, the ForeseeHome®, uses preferential hyperacuity perimetry for early detection of choroidal neovascularisation before symptoms develop.
Real-world strategies for wet AMD
February 29th 2016In many clinical areas, early consultant-led intervention has been shown to improve clinical and patient-reported outcomes and to reduce overall treatment costs. This paper reconfirms this finding in the treatment of wet age-related macular degeneration (wet AMD) and presents data from a publicly funded NHS fast-track (FT) centre in north-west England that aims to see and treat patients within 48 hours of referral.
Latest concepts in steroid therapy for diabetic macular oedema
February 29th 2016Steroids are an important second-line treatment for the treatment of diabetic macular oedema. While side effects remain a concern, modern formulations of intravitreal steroid allow the treatment to be tailored to the individual patient.
Mixed results for neovascular AMD gene therapy
February 29th 2016In a Phase IIa study of patients with neovascular age-related macular degeneration, a single subretinal injection of rAAV.sFlt-1 gene therapy (AVA-101) demonstrated acceptable safety, but not a complete or durable response. Additional preclinical research is underway.
Are extended-depth-of-focus IOLs hitting the visual sweet spot?
February 29th 2016Current IOL designs offer a variety of optical options for the correction of presbyopia. Regardless of the principal of correction, compromise is required. However, a new class of IOLs, currently referred to as extended-depth-of-focus IOLs (EDOF-IOLs), seems to be generating very satisfied patients.
Redefining cyclophotocoagulation with modified laser delivery [ABSTRACT]
February 29th 2016While traditional transscleral cyclophotocoagulation is effective at lowering IOP in patients with glaucoma, it has a high rate of side effects. The new MicroPulse system is effective and affordable with an excellent safety profile.
Adjustable intraocular lenses after cataract surgery
February 18th 2016Incorrect IOL power is one of the most frequent reasons for IOL exchange following cataract surgery. Different options for the correction of residual refractive errors are being developed, including piggyback IOLs, light-adjustable lenses and multicomponent IOLs.
Novel software measures vessel tortuosity in ROP
January 20th 2016The Novel Evidenced Assessment of Tortuosity (NEAT) system is intuitive and works even with poor images, according to its creators, Konstantinos Balaskas and his colleagues at Manchester Royal Eye Hospital and five other centres in the United Kingdom.
Reducing posterior capsular rupture
January 12th 2016Rounded phaco tips reduce the risk of posterior capsule rupture, increasing the safety of phacoemulsification. The Dewey Radius Tip, which is used exactly like a sharp-edged phaco needle, has rounded edges. This reduces the risk of posterior capsule rupture during cataract surgery.
Validating long-term toric IOL performance
January 1st 2016Five years of experience with the Rayner T-flex aspheric IOL show it to be a safe, highly effective long-term method of correcting the widest possible range of sphere and cylinder errors in pseudophakic patients with pre-existing corneal astigmatism.
Why 'the more the merrier' doesn't apply to glaucoma monitoring
December 1st 2015Though ocular hypertension may be the only modifiable risk factor for glaucoma, the second-leading cause of sight loss in the United Kingdom, monitoring for ocular hypertension more than twice a year is not efficient, researchers said.
CXL with epithelial disruption safely and effectively treats ectasia
April 8th 2015Corneal collagen crosslinking (CXL) with epithelial disruption appears to safely and effectively treat keratoconus or iatrogenic corneal ectasia, according to a study recently published in Eye. In fact, patients may tolerate the approach better than they tolerate the technique involving complete removal of the epithelium, say the authors, from the Corneoplastic Unit and Eye Bank of Queen Victoria Hospital in East Grinstead, UK.